Billing Codes

CCSD Code Q0880: Hysterectomy for Ovarian Tumour Billing Guide

Key Takeaways

Key Takeaways

CCSD code Q0880 covers hysterectomy with excision/biopsy and/or removal of omentum and uterine adnexa for ovarian tumour, with or without ureterolysis.

Q0880 carries an Xmajor complexity grade, which affects anaesthetic fees, assistant surgeon fees, and facility charges.

Freedom Health Insurance lists the surgeon fee for Q0880 at £850.00 and the assistant fee at £357.00 (effective 01/11/2025); always verify current rates directly with each insurer.

Ureterolysis, when performed as part of Q0880, is included within the procedure and is not separately claimable under most insurer schedules.

Q0880 differs from Q0890, which covers vaginal hysterectomy including salpingo-oophorectomy; accurate code selection between these two depends on surgical approach and the presence of ovarian malignancy.

Gynaecology billing in UK private healthcare leaves little room for ambiguity. Submit the wrong code for a complex hysterectomy and you risk claim rejection, insurer queries, or underpayment that can take months to resolve. CCSD procedure codes provide the industry standard for private procedure billing, and for ovarian tumour-related hysterectomy, CCSD code Q0880 is the code that governs reimbursement across the major UK insurers.

This guide covers everything gynaecology specialists and their billing teams need to know about CCSD code Q0880: its exact clinical description, how it sits within the CCSD schedule, what the Xmajor grading means for your claim, which insurers pay what, and how it compares to Q0890. Whether you are building a billing workflow for a new private practice or reviewing a persistent denial pattern, this reference gives you the operational detail to get it right.

CCSD Code Q0880: Procedure Description and Clinical Context

Most claim errors on complex gynaecological procedures start with a misread description. CCSD code Q0880 describes a specific and demanding procedure: hysterectomy with excision and/or biopsy and/or removal of the omentum and uterine adnexa for an ovarian tumour, with or without ureterolysis. That final qualifier, “+/- ureterolysis,” is one of the most frequently misunderstood elements of this code, and it directly affects whether a separate urology code can be claimed alongside it.

What the Procedure Covers

The procedure captured by CCSD code Q0880 is a major open gynaecological operation performed in the context of confirmed or suspected ovarian malignancy or significant ovarian pathology. It typically includes removal of the uterus, one or both ovaries, the fallopian tubes (salpingo-oophorectomy), and may extend to omental biopsy or omentectomy when peritoneal spread is suspected. This is cytoreductive surgery in its most common UK private setting, carried out by a gynaecological oncologist or senior gynaecology consultant.

Ureterolysis, when required, is performed to free the ureter from peritoneal adhesions or tumour involvement to allow safe uterine removal. Under the CCSD schedule, this is considered included within the Q0880 procedure. The code for prosthesis insertion into the ureter is explicitly designed for urologists inserting stents and does not apply when ureter identification occurs as part of hysterectomy, a distinction confirmed by AXA Health’s own Chapter 14 guidance notes.

CCSD Code Q0880 Chapter 14 Classification

Q0880 sits within CCSD Chapter 14: Female Reproductive Organs, the chapter governing private billing for all gynaecological procedures. Chapter 14 covers the full spectrum of gynaecological surgery, from diagnostic laparoscopy through to major oncological resection. Knowing the chapter matters in practice because insurers organise their fee schedules, prior authorisation requirements, and clinical notes expectations by chapter. When querying a Q0880 claim with AXA Health or Bupa, referencing Chapter 14 in correspondence will direct the query to the right clinical assessment team.

CCSD Code Q0880 Fee Schedule by Insurer

Fee schedules for CCSD code Q0880 vary significantly between insurers, and several major insurers do not publish their rates publicly. The figures below represent rates confirmed through published fee schedule documents and should be verified directly with each insurer before invoicing, as schedules are updated periodically.

Insurer Surgeon Fee Assistant Fee Notes
Freedom Health Insurance £850.00 £357.00 Effective 01/11/2025. Freedom Elite schedule.
Guernsey Private Fees £7,200.00 N/A 2021 published schedule; confirm current rates directly.
AXA Health Contact insurer Contact insurer Chapter 14 schedule; rates available via AXA specialist portal.
Bupa Contact insurer Contact insurer Use Bupa code search tool for current rates.
Allianz Care Contact insurer Contact insurer CCSD-based national fee schedule effective December 2024.

The variation in how insurers present their Q0880 rates reflects broader differences in how UK private health insurers structure their gynaecology fee schedules. Freedom Health publishes a granular procedure-level schedule, while larger insurers such as Bupa and AXA Health use recognition agreements that tie surgical fees to individual specialist contracts. For private gynaecology practices with multiple insurer relationships, maintaining an up-to-date fee schedule register for Q0880 and related codes is an essential part of revenue cycle management.

CCSD Code Q0880: AXA Health Chapter 14 Billing Notes

AXA Health’s Chapter 14 specialist procedure code page includes specific notes that affect how gynaecology claims are processed. One note clarifies that the benefit for therapeutic laparoscopy includes an amount for diagnostic laparoscopy, meaning these cannot be separately billed when performed in the same episode. Another note explicitly states that the ureter prosthesis insertion code applies only to urologists inserting stents, not to ureteral identification during hysterectomy. These two notes directly govern how Q0880 claims interact with related codes and are essential reading for any practice billing this procedure to AXA.

Pro Tip

Before submitting a Q0880 claim to any insurer, cross-check whether ureterolysis was documented separately in the operative notes. If it was performed as part of the hysterectomy and not as a distinct procedure requiring independent clinical decision-making, do not attempt to bill it separately. Doing so will likely trigger an insurer query and may result in clawback.

CCSD Code Q0880: Chapter 14 Classification and Xmajor Grading

The Xmajor complexity grade assigned to CCSD code Q0880 places it in the highest tier of surgical complexity within the CCSD schedule. Understanding what Xmajor means in practice is essential for accurate billing of anaesthetic, assistant surgeon, and facility fees, all of which are linked to the primary procedure grade.

Xmajor Grading: Billing Implications

CCSD complexity grades run from minor through to Xmajor, with Xmajor reserved for the most complex surgical procedures. For Q0880, the Xmajor designation reflects the combination of major abdominal surgery, potential oncological staging, omentectomy, and the need for ureteral dissection in a potentially hostile operating field.

  • Anaesthetic fees: Anaesthetists billing for Xmajor procedures can claim at the highest anaesthetic fee tier. The anaesthetic fee is typically calculated based on the procedure grade and time, using insurer-specific formulae.
  • Assistant surgeon fees: An assistant surgeon fee is claimable for Xmajor procedures. Freedom Health, for example, sets the Q0880 assistant fee at £357.00. Insurers generally require documentation confirming that a surgeon assistant was present and clinically necessary.
  • Facility charges: Xmajor procedures attract higher theatre and facility charges from the hospital or independent treatment centre. These are billed by the facility, not the surgeon, but the Xmajor designation on the surgeon’s invoice helps the facility cross-reference the procedure when submitting its own claim.
  • Inpatient care designation: As an Xmajor procedure, Q0880 is always claimed as an inpatient episode. Post-operative inpatient stay fees are claimable by the person in primary charge of the case, with other specialists billing only for specific consultations.

Practices using claims management software that integrates with Healthcode can automate the linkage between procedure grade and fee calculation, reducing the manual checking burden on billing staff. The CCSD Technical Guide and Business Rules (October 2025) provides the definitive reference for how complexity grades apply across the schedule.

Q0880 does not exist in isolation. Several adjacent codes in Chapter 14 are regularly billed alongside or instead of it, and selecting the wrong one will result in a rejected or underpaid claim.

CCSD Code Description Grade Key Distinction
Q0880 Hysterectomy with excision/biopsy and/or removal of omentum and uterine adnexa for ovarian tumour +/- ureterolysis Xmajor Ovarian tumour context; open approach implied
Q0890 Vaginal hysterectomy including salpingo-oophorectomy (including laparoscopically assisted) +/- ureterolysis Major Vaginal/LAVH approach; no omentum involvement
Q0920 Myomectomy (including laparoscopically) Major Fibroid removal; uterus preserved

Streamline private gynaecology billing with Pabau

Pabau supports CCSD billing workflows for UK private healthcare providers, with Healthcode integration, digital clinical documentation, and automated claim management to reduce errors and speed up reimbursement.

Pabau practice management platform for UK private healthcare

CCSD Code Q0880 vs Q0890: Choosing the Right Code

The most common coding error on complex hysterectomies in UK private practice is billing CCSD code Q0880 when Q0890 applies, or vice versa. Both codes include hysterectomy with salpingo-oophorectomy and both permit ureterolysis, but the clinical contexts and surgical approaches are distinct enough that the codes are not interchangeable.

CCSD Code Q0880: Ovarian Malignancy and Open Approach

Q0880 is the appropriate code when the primary indication is an ovarian tumour and the surgery extends to omentum excision or biopsy, whether or not ureterolysis is required. The procedure is characteristically performed as an open abdominal operation, though the CCSD description does not explicitly state this. The critical differentiator is the oncological or tumour-related indication and the inclusion of omental work, which places the procedure well beyond a standard bilateral salpingo-oophorectomy in complexity.

When documentation references cytoreductive surgery, staging laparotomy, or omentectomy for suspected ovarian malignancy, Q0880 is the code to use. Insurers expect the operative note to confirm the presence of an ovarian tumour, the extent of the resection, and whether ureterolysis was required. Missing any of these elements in the clinical record is one of the most common reasons Q0880 claims are queried rather than paid first time.

Q0890: Vaginal and Laparoscopically Assisted Hysterectomy

Q0890 covers vaginal hysterectomy including salpingo-oophorectomy, whether performed entirely vaginally or with laparoscopic assistance (LAVH). The code also includes ureterolysis when required. It does not include omentectomy or omental biopsy, which is the defining clinical boundary between the two codes.

Q0890 carries a Major rather than Xmajor complexity grade, reflecting the typically less complex operative field compared to open oncological surgery. Billing Q0890 instead of Q0880 for an open cytoreductive procedure will result in underpayment and may require resubmission with an amended code, a process that delays revenue by four to eight weeks in most insurer workflows. For consultants moving from NHS to private practice, understanding this distinction early prevents a pattern of systematic underclaiming on the highest-complexity procedures in a gynaecology caseload.

Pro Tip

Review your operative notes template for major gynaecology cases. Ensure it includes fields for surgical approach (open vs laparoscopic), indication (ovarian tumour, benign pathology, etc.), omental involvement (yes/no with extent), and whether ureterolysis was performed. A well-structured operative note eliminates the most common reasons for Q0880 claim queries at source.

CCSD Code Q0880 Documentation and Billing Requirements

Getting paid for CCSD code Q0880 on first submission requires the right documentation in place before the claim is sent. UK private insurers process Q0880 as a complex oncological procedure, and their clinical assessors will apply higher scrutiny than they would for routine gynaecological codes. The documentation requirements below reflect the current expectations of the major UK insurers.

Documentation Checklist for CCSD Code Q0880

  • Operative note: Must confirm hysterectomy was performed, specify the surgical approach, document omental involvement (excision or biopsy), confirm bilateral or unilateral adnexal removal, and note whether ureterolysis was required and why.
  • Histopathology request: A pathology request form confirming specimen submission for the omentum and adnexa supports the oncological indication. Insurers may request this when auditing complex claims.
  • Pre-operative imaging or biopsy report: A pre-operative ultrasound, CT, or biopsy report confirming the ovarian tumour provides the clinical justification for Q0880 rather than a simpler hysterectomy code.
  • Consultant referral or MDT note: For oncological cases, a multidisciplinary team discussion note or referring consultant letter strengthens the clinical record and supports the complexity grading.
  • Anaesthetic record: The anaesthetist’s own record, when submitted alongside the surgeon’s claim, provides corroborating evidence of procedure duration and complexity for Xmajor fee calculation.
  • Assistant surgeon confirmation: If claiming an assistant fee, confirm in writing that a surgeon assistant was present, identify that person, and note their role in the operative record.

Private practices using digital clinical forms that feed directly into a patient record can automate the capture of most of this documentation at point of care, reducing the administrative burden on billing staff who otherwise need to chase records retrospectively before claim submission.

Claim Submission via Healthcode

The vast majority of UK private healthcare claims are submitted electronically via Healthcode, the EDI platform used by insurers including Bupa, AXA Health, Freedom Health, and others. When submitting a Q0880 claim through Healthcode, include the CCSD code, the date of procedure, the consultant’s specialist registration number, and the facility identifier. If the assistant surgeon is also billing, their claim is submitted separately under their own registration number, referencing the same episode.

Claim rejections on Q0880 most commonly arise from three sources: the wrong code in the code field (typically Q0890 used in error), missing clinical documentation when the insurer requests supporting evidence, and incorrect assistant fee claims where the insurer does not have the assistant on their recognition list. All three are preventable with a structured pre-submission check. Compliance management tools within practice management platforms can build these checks into the billing workflow, flagging incomplete submissions before they reach the insurer.

Additional CCSD Code Q0880 Billing Considerations

Several billing scenarios arise regularly with CCSD code Q0880 that are worth addressing directly, particularly for practices new to billing complex gynaecological oncology cases privately.

Laparoscopic vs Open Approach

The current CCSD description for Q0880 does not differentiate between open and laparoscopic approaches. In practice, the most common presentation is open surgery given the oncological complexity, but where a laparoscopic or robotic approach is used for tumour removal and omental work, the same Q0880 code applies unless the CCSD Technical Guide or your insurer’s schedule specifies otherwise. Always verify current rules with the relevant insurer before billing a laparoscopic Q0880, as some insurers may apply different fee arrangements for minimally invasive oncological procedures. The Bupa CCSD codes guide provides useful context on how Bupa handles approach-related billing nuances across the CCSD schedule.

Private Healthcare Information Network Reporting

The Private Healthcare Information Network (PHIN) requires UK private hospitals and independent treatment centres to report procedure volumes using CCSD codes. Q0880 data feeds into PHIN’s published outcomes reporting for gynaecological oncology. For consultants operating under a hospital’s CQC registration, accurate CCSD coding is therefore not just a billing function but also a quality reporting obligation. Inaccurate coding, including systematic use of Q0890 where Q0880 is appropriate, will produce distorted PHIN data and may attract scrutiny from both the insurer and the hospital’s clinical governance team.

Practices looking to establish robust private gynaecology billing from the outset will benefit from integrating their practice management planning with dedicated CCSD billing workflows early, rather than retrofitting billing processes after patterns of error have already developed. The Allianz Care UK Recognition Fee Schedule, effective from December 2024, provides a comprehensive CCSD-coded reference that practices can use to benchmark their fee expectations across multiple insurers simultaneously.

Expert Picks

Expert Picks

Need a complete overview of how CCSD codes work across UK private healthcare? Bupa CCSD Codes: Complete Guide for UK Clinics covers code structure, insurer submission requirements, and common billing pitfalls for the full CCSD schedule.

Managing claims, denials, and resubmissions across multiple insurers? Pabau Claims Management Software supports CCSD billing workflows with Healthcode integration and automated claim tracking.

Running a multi-consultant gynaecology or women’s health practice? Pabau OB/GYN EMR Software is built for the documentation and billing requirements of private gynaecology, including complex oncology cases.

Handling UK private billing compliance and documentation standards? Pabau Compliance Management Software helps private practices maintain audit-ready records aligned with insurer and PHIN requirements.

Conclusion

Accurate billing for complex gynaecological oncology procedures comes down to two things: the right code and the right documentation. CCSD code Q0880 is a highly specific code reserved for hysterectomy with omental and adnexal work in the context of ovarian tumour, and its Xmajor grading carries real financial implications for anaesthetic, assistant, and facility fees. Getting it right on first submission requires a structured pre-claim documentation check and a clear understanding of where Q0880 ends and Q0890 begins.

Pabau’s claims management tools support UK private healthcare providers in building the billing workflows that prevent these errors before they reach the insurer. To see how Pabau supports CCSD billing for gynaecology and other specialties, book a demo with the team.

Frequently Asked Questions

Is ureterolysis separately billable when performing Q0880?

No. Under the CCSD schedule, ureterolysis performed as part of a Q0880 hysterectomy is included within the procedure code and cannot be separately claimed. The code for ureter prosthesis insertion applies only to urologists inserting stents independently, not to ureteral identification or dissection during hysterectomy. Attempting to bill ureterolysis separately alongside Q0880 is likely to trigger an insurer query or denial.

What is the difference between Q0880 and Q0890 in CCSD billing?

Q0880 covers hysterectomy with omental and adnexal excision in the context of an ovarian tumour, typically via an open abdominal approach, and carries an Xmajor complexity grade. Q0890 covers vaginal hysterectomy including salpingo-oophorectomy, whether vaginal or laparoscopically assisted, without omental involvement, and carries a Major grade. The key clinical differentiators are the presence of an ovarian tumour indication, omentectomy or omental biopsy, and surgical approach.

Can an assistant surgeon fee be claimed on a Q0880 procedure?

Yes. Q0880’s Xmajor complexity grade entitles the operating team to claim an assistant surgeon fee, provided the assistant’s presence is documented in the operative record and the assistant is recognised by the insurer. Freedom Health, for example, sets this fee at £357.00 for Q0880 under their November 2025 schedule. Insurers may require the assistant surgeon to submit their claim separately under their own recognition number.

Does Q0880 apply to laparoscopic oncological hysterectomy?

The current CCSD description for Q0880 does not specify surgical approach, so it may apply to laparoscopic or robotic approaches as well as open surgery. However, insurers may have internal guidance on fee arrangements for minimally invasive approaches to this procedure. Verify with the specific insurer before billing a laparoscopic Q0880, and document the approach and extent of omental work clearly in the operative notes.

Which UK insurers cover Q0880 and how do I find their current rates?

All major UK private health insurers, including Bupa, AXA Health, Freedom Health, Allianz Care, and The Exeter, recognise CCSD code Q0880. Published rates are available from Freedom Health’s Chapter 14 fee schedule and the Allianz Care UK Recognition Fee Schedule. Bupa rates are accessible via the Bupa code search tool for recognised specialists. AXA Health rates are available through the AXA specialist portal. Rates change periodically, so verify directly with each insurer before invoicing.

×